NCT02048293View on ClinicalTrials.gov

Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Pain
Interventions
DRUG

Remifentanyl, Ultiva®

Anesthetic induction for orotracheal intubation. Group O

DRUG

Remifentanil Laboratorios Chalver de Colombia S.A.

Anesthetic induction for orotracheal intubation. Group A

DRUG

Fada Remifentanilo

Anesthetic induction for orotracheal intubation. Group B

Trial Locations (1)

11001000

Fundación Universitaria de Ciencias de la Salud, Hospital de San Jose, Bogota

All Listed Sponsors
collaborator

Hospital de San Jose

OTHER

lead

Fundación Universitaria de Ciencias de la Salud

OTHER

NCT02048293 - Pharmacodynamic Differences Between Branded and Unbranded Remifentanil Molecules | Biotech Hunter | Biotech Hunter